Rethinking Clinical Trials Grand Rounds: Strategies for Improving Public Understanding of FDA and the Products It Regulates

Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do?

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

Susan C. Winckler, RPh, Esq
Chief Executive Officer
Reagan-Udall Foundation for the FDA

Learn More